Core Scientific Gestione
Criteri Gestione verificati 2/4
Core Scientific Il CEO è Adam Sullivan, nominato in May2023, e ha un mandato di 2.33 anni. la retribuzione annua totale è $ 22.92M, composta da 3.6% di stipendio e 96.4% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.72% delle azioni della società, per un valore di $ 45.47M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 2.3 anni e 2.3 anni.
Informazioni chiave
Adam Sullivan
Amministratore delegato
US$22.9m
Compenso totale
| Percentuale dello stipendio del CEO | 3.56% |
| Mandato del CEO | 3yrs |
| Proprietà del CEO | 0.7% |
| Durata media del management | 2.3yrs |
| Durata media del Consiglio di amministrazione | 2.3yrs |
Aggiornamenti recenti sulla gestione
Recent updates
CORZ: AI Hosting Ramp And Power Buildout Are Expected To Drive Upside
Analysts have adjusted the Core Scientific fair value estimate from $37.43 to $35.65, reflecting updated assumptions around higher projected revenue growth and profit margins, along with a lower future P/E multiple and a slightly refined discount rate based on recent research highlighting progress in AI hosting capacity, lease expectations, and HPC expansion. Analyst Commentary Recent Street research points to generally constructive sentiment around Core Scientific, with several bullish analysts refining models as new information comes through on AI hosting progress, lease timing, and high performance computing capacity.
CORZ: AI Hosting Contracts And Power Expansion Will Drive Future Upside
Analysts have raised their blended price target on Core Scientific by a few dollars, placing it in the low to mid $20s. They cite progress on AI hosting contracts, expanded power capacity, and an ongoing shift in the power portfolio from Bitcoin mining toward high performance compute.CORZ: AI Hosting Shift And Lease Pipeline Will Drive Future Upside
Analysts have nudged the Core Scientific price target slightly lower, with the updated fair value estimate moving from about $26.82 to $26.40. They are weighing higher projected revenue growth and profit margins against revised P/E assumptions and recent research highlighting organic growth plans, AI hosting expansion and an evolving lease pipeline.
CORZ: AI Hosting Expansion And Texas Power Capacity Will Drive Future Upside
Analysts lifted their Core Scientific fair value estimate to $20 from $17, pointing to progress on new Texas capacity, AI hosting expansion, and expectations around additional lease signings as key drivers behind the higher price target range across recent research updates. Analyst Commentary Street research on Core Scientific has been active, with several firms updating their views around the company’s shift toward AI and high performance compute hosting, the timing of new lease signings, and the evolving power portfolio.CORZ: Power Shift To High Performance Compute Will Support Future Contracts
Analysts have lifted their $-denominated price targets on Core Scientific, with one firm increasing its view by $6. They point to steadier discount rate assumptions, slightly higher projected revenue growth and margins, and a lower future P/E multiple supported by expectations for additional high performance compute contracts after the failed CoreWeave merger.CORZ: Power Footprint Conversion To High Performance Compute Will Drive Next Phase
Analysts have trimmed their fair value estimate for Core Scientific from US$37.71 to US$37.43, citing updated assumptions around discount rates, revenue growth, margins and future P/E after recent price target changes and research highlighting both regulatory risks for crypto and potential long term upside from high performance computing contracts. Analyst Commentary Recent Street research around Core Scientific has highlighted a mix of crypto related policy risk and optimism around the company’s push into high performance computing, with some research pointing to potential valuation upside if execution on new contracts goes to plan.CORZ: Future Compute Contracts And Crypto Exposure Balance Fair Opportunity And Risk
Narrative Update The analyst price target for Core Scientific has shifted from US$15.00 to US$17.00 as analysts factor in improved profit margin assumptions, a lower modeled discount rate, and recent research that points to potential value creation from the company pursuing high performance compute contracts following the terminated CoreWeave merger. Analyst Commentary Recent research coverage has shifted toward a more constructive tone on Core Scientific, with several firms lifting ratings and price targets following the terminated CoreWeave merger and increased focus on high performance compute opportunities.CORZ: Power Footprint And HPC Contracts Will Define Next Phase
Narrative Update: Core Scientific Analyst Price Target Move The analyst price target for Core Scientific has shifted from roughly US$23.00 to about US$37.71. Analysts attribute this change to the resolution of the CoreWeave merger overhang, a renewed focus on high performance compute colocation contracts, and the perceived value of the company’s power infrastructure.Core Scientific: Buying This AI Data Center Winner Into Recent Weakness
Dec 17CORZ: Standalone AI Power Pipeline Will Drive Future Upside Potential
Analysts have trimmed their fair value estimate for Core Scientific by about $0.83 per share to $26.82, reflecting a slightly higher discount rate even as they highlight improved standalone prospects, reduced deal overhang, and stronger AI infrastructure optionality as key supports for the updated price target. Analyst Commentary Recent Street research reflects a largely constructive shift in sentiment on Core Scientific, with multiple firms raising ratings and price targets as the market pivots to a standalone, AI and high performance compute oriented narrative following the termination of the CoreWeave merger.CORZ: Terminated Merger Will Unlock New Upside With Power Pipeline Expansion
Analysts have modestly raised their price target for Core Scientific to $27 from $23, citing the terminated merger and increased confidence in the company’s standalone prospects as key factors supporting improved valuation. Analyst Commentary Recent street research reflects a range of perspectives on Core Scientific's prospects as a standalone company, especially after the terminated merger.CORZ: Standalone Operator Status Will Unlock New Upside This Year
Analysts have increased their fair value price target for Core Scientific from $25.25 to $27.65. They cite renewed confidence in the company's standalone prospects and the removal of merger-related overhangs as reasons for this adjustment.CORZ: Power Portfolio And AI Demand Will Unlock Substantial Upside
Core Scientific's analyst price target has increased significantly from $20.88 to $25.25 per share. This change reflects analysts' optimism following the terminated merger with CoreWeave and improved standalone growth prospects for the company.HPC Expansion And Diversified Contracts Will Create Future Resilience
Analysts have raised their price target for Core Scientific from $19.95 to $20.88 per share, citing strong sector momentum from major data center deals and an improved profit margin outlook. Analyst Commentary Analyst discussions surrounding Core Scientific have highlighted both promising industry dynamics and company-specific considerations that could influence future performance and valuation.HPC Expansion And Diversified Contracts Will Create Future Resilience
Analysts have raised their price target for Core Scientific from $19.05 to $19.95 per share, citing updated deal terms and ongoing re-evaluation of merger economics following CoreWeave's acquisition agreement. Analyst Commentary Analysts continue to weigh the implications of Core Scientific's pending acquisition by CoreWeave, with a mix of optimism for the company's positioning and caution regarding valuation and deal structure.HPC Expansion And Diversified Contracts Will Create Future Resilience
Consensus analyst price targets for Core Scientific have risen slightly to reflect the strategic value of its infrastructure assets highlighted by the announced CoreWeave acquisition, despite some uncertainty regarding realized shareholder value and potential downside to deal economics, resulting in a revised fair value of $19.05. Analyst Commentary The announced acquisition of Core Scientific by CoreWeave in an all-stock transaction prompted widespread price target reductions and downgrades to Neutral/Hold/Perform, reflecting diminished standalone upside and uncertainty regarding the ultimate value realized by Core Scientific shareholders.
HPC Expansion And Diversified Contracts Will Create Future Resilience
Reallocating resources from Bitcoin mining to HPC infrastructure could drive future growth amid rising data center demands and diversified clientele.The AI Awakening Of Core Scientific
Mar 18DeepSeek, Market Volatility, False Rumor Create Opportunity In Core Scientific
Mar 09Core Scientific: Higher Digital Asset Prices And Making Progress On Debt
Jan 12Core Scientific: HPC Pivot Begins To Bear Fruit
Oct 16Core Scientific: Deserves Better As HPC Moves Into High Gear
Aug 13Core Scientific: HPC Deals And A Buyout Offer
Jun 04Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Utili della società |
|---|---|---|---|
| Dec 31 2025 | US$23m | US$816k | -US$281m |
| Sep 30 2025 | n/a | n/a | -US$654m |
| Jun 30 2025 | n/a | n/a | -US$850m |
| Mar 31 2025 | n/a | n/a | -US$1b |
| Dec 31 2024 | US$42m | US$563k | -US$1b |
| Sep 30 2024 | n/a | n/a | -US$1b |
| Jun 30 2024 | n/a | n/a | -US$831m |
| Mar 31 2024 | n/a | n/a | -US$35m |
| Dec 31 2023 | US$1m | US$378k | -US$246m |
Compensazione vs Mercato: La retribuzione totale di Adam ($USD 22.92M ) è superiore alla media delle aziende di dimensioni simili nel mercato US ($USD 8.54M ).
Compensazione vs guadagni: La retribuzione di Adam è stata coerente con le performance aziendali dell'ultimo anno.
AMMINISTRATORE DELEGATO
Adam Sullivan (33 yo)
3yrs
Mandato
US$22,923,204
Compensazione
Mr. Adam Sullivan serves as President of Core Scientific, Inc. since May 15, 2023 and serves as its Chief Executive Officer from August 2, 2023. He was a Managing Director and Head of Digital Assets and In...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO, President & Director | 3yrs | US$22.92m | 0.72% $ 45.5m | |
| Executive VP & CFO | 1.2yrs | US$9.80m | 0.12% $ 7.5m | |
| Executive VP | 7.1yrs | US$7.42m | 0.63% $ 40.0m | |
| Chief Operating Officer | 1.9yrs | Nessun dato | Nessun dato | |
| Chief Accounting Officer | less than a year | Nessun dato | Nessun dato | |
| Chief Technology Officer | 2.3yrs | Nessun dato | Nessun dato | |
| Vice President of Investor Relations | 1.2yrs | Nessun dato | Nessun dato | |
| Executive Vice President of Corporate Development & Strategy | 2.3yrs | Nessun dato | Nessun dato | |
| Chief Human Resources Officer | 1.3yrs | Nessun dato | Nessun dato | |
| Chief Information Security Officer | no data | Nessun dato | Nessun dato | |
| Chief Development Officer | 9.3yrs | Nessun dato | Nessun dato | |
| Senior VP of Tax & Trade | 7.4yrs | Nessun dato | Nessun dato |
2.3yrs
Durata media
55yo
Età media
Gestione esperta: Il team dirigenziale di CORZ è considerato esperto (durata media dell'incarico 2.3 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO, President & Director | 2.3yrs | US$22.92m | 0.72% $ 45.5m | |
| Independent Director | 1yr | US$576.57k | Nessun dato | |
| Independent Chairman | 2.3yrs | US$445.41k | 0.057% $ 3.6m | |
| Independent Director | 2.3yrs | US$401.97k | 0.022% $ 1.4m | |
| Independent Director | 2.3yrs | US$424.47k | 0.098% $ 6.2m | |
| Independent Director | 2.3yrs | US$401.97k | 0.034% $ 2.1m |
2.3yrs
Durata media
54.5yo
Età media
Consiglio di amministrazione esperto: Il consiglio di amministrazione di CORZ non è considerato esperto (durata media del mandato 2.3 anni), il che suggerisce un nuovo consiglio.
Analisi aziendale e situazione dei dati finanziari
| Dati | Ultimo aggiornamento (ora UTC) |
|---|---|
| Analisi dell'azienda | 2026/05/01 07:47 |
| Prezzo dell'azione a fine giornata | 2026/05/01 00:00 |
| Utili | 2025/12/31 |
| Utili annuali | 2025/12/31 |
Fonti dei dati
I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.
| Pacchetto | Dati | Tempistica | Esempio Fonte USA * |
|---|---|---|---|
| Dati finanziari della società | 10 anni |
| |
| Stime di consenso degli analisti | +3 anni |
|
|
| Prezzi di mercato | 30 anni |
| |
| Proprietà | 10 anni |
| |
| Gestione | 10 anni |
| |
| Sviluppi principali | 10 anni |
|
* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.
Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.
Modello di analisi e Snowflake
I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; abbiamo anche guide su come utilizzare i nostri report e tutorial su Youtube.
Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.
Metriche di settore e industriali
Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.
Fonti analitiche
Core Scientific, Inc. è coperta da 21 analisti. 15 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.
| Analista | Istituzione |
|---|---|
| Ramsey El-Assal | Barclays |
| Gautam Chhugani | Bernstein |
| Nicholas Giles | B. Riley Securities, Inc. |